Anticoagulant therapy, anti-platelet agents and gastrointestinal endoscopy.

摘要: Background: The increasing use of anticoagulant therapy and anti-platelet agents in the primary secondary prevention cardiovascular, cerebrovascular venous thromboembolic disease has increased need for guidelines managing these prior to gastrointestinal endoscopy, particularly if therapeutic manoeuvres are required. continuation increases risk haemorrhagic complications endoscopy. Temporary suspension exposes patient thromboembolism associated with underlying condition requiring treatment. Conclusions: This article reviews literature proposes management patients taking who require